As a result of a long-term collaboration between the SciLifeLab Swedish NMR (Nuclear magnetic resonance) centre and AstraZeneca, advanced Dynamic Nuclear Polarization (DNP) NMR is available for both academia and industry. This cutting-edge instrument, which is much faster than previous versions, can analyze samples in minutes rather than days, months or even years, and is vital for drug development.
